Stocks-ABBV-AbbVie Inc

ABBV AbbVie Inc

182.54 0.4051 (0.22%)
Market Closed Delayed prices by NASDAQ, in USD
Stocks-ABBV-AbbVie Inc
ABBV AbbVie Inc

Overview

Prev Close 182.54
Day's Range 181.31 - 183.78
52 Week Range 153.30 - 218.23
Average Volume (3M) 8.11M
1-Year Return 15.73%
Beta0.3646
Market Cap 322.44B
P/E Ratio77.84
Revenue57.37B
EPS2.3452
Dividend (Yield) 6.38 (3.49%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Robert A. Michael, MBA, CPA
Employees
55,000

FINANCIAL SUMMARY

For the quarter ended 31/3/2025, AbbVie Inc's revenues decreased by 11.65% and amounted to 13.34B. Net income increased by 5,730.43% to 1.3B. Net assets decreased by 0 to 0 and EPS increased from -0.02 to 0.72.
ABBV's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income06/2409/2412/2403/25-5B05B10B15B20B
Gross Margin
70.80%
Net Profit Margin
13.41%
Operating Margin
30.74%
Return On Investment
9.75%
06/24
09/24
12/24
03/25
Total Revenue
14.46B
14.46B
15.1B
13.34B
Gross Profit
12.29B
10.27B
12.6B
11.2B
Operating Income
5.08B
3.96B
204M
4B
Net Income
1.38B
1.55B
-23M
1.3B